Phathom Pharmaceuticals Surpasses Q4 Expectations with Non-GAAP EPS and Revenue Figures
Thursday, 7 March 2024, 13:04
Phathom Pharmaceuticals Q4 Financial Results
Phathom Pharmaceuticals recently announced its fourth-quarter financial results, surprising investors and analysts alike with its stellar performance.
Key Highlights:
- Non-GAAP EPS: Phathom Pharmaceuticals reported Non-GAAP EPS of -$0.80, surpassing expectations by $0.20.
- Revenue: The company generated $0.68M in revenue, beating estimates by $0.3M.
This exceptional performance positions Phathom Pharmaceuticals as a promising player in the pharmaceutical industry, signaling potential growth opportunities for investors.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.